Dipartimento Di Salute Della Donna E Del Bambino
- Address
- lock Available on a paid plan
Dipartimento Di Salute Della Donna E Del Bambino - Pediatric Immunology and Oncology Research Center
The Dipartimento Di Salute Della Donna e Del Bambino (Department of Women's and Children's Health) is a specialized research institution dedicated to advancing pediatric care through innovative clinical trials. The center focuses on complex immune-mediated diseases and hematologic malignancies affecting children, adolescents, and young adults, with particular expertise in developing age-appropriate therapeutic interventions.
- Pediatric systemic lupus erythematosus (SLE) and autoimmune disorders
- Relapsed or refractory lymphomas, including classical Hodgkin lymphoma and non-Hodgkin lymphoma
- Immunotherapy combinations and novel biologic agents in pediatric populations
The department conducts sophisticated pharmacokinetic studies to determine optimal dosing regimens for children and adolescents, recognizing that pediatric patients require specialized approaches distinct from adult protocols. Their research portfolio includes investigations of immune checkpoint inhibitors and type I interferon pathway modulators, with emphasis on characterizing safety profiles and establishing maximum tolerated doses in younger patient populations. The center's commitment to pediatric precision medicine ensures that emerging therapies are appropriately adapted for children facing serious autoimmune conditions and malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dipartimento Di Salute Della Donna E Del Bambino
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 1/2 Evaluation of Relatlimab and Nivolumab in Pediatric and Young Adult Patients with Recurrent or Refractory Classical Hodgkin and Non-Hodgkin Lymphoma | Bristol Myers Squibb International Corporation | Phase I | Not Recruiting | Dec 2022 | Dec 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Nivolumab | 1 | Unknown | 2022-12-29 | 2022-12-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.